Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

BSE’s index option premium market share had earlier shot up to 22.1 per cent in February 2025 from 16.4 per cent in December ...

While the central bank's easing measures may provide short-term relief, global uncertainties—such as a US growth slowdown and ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

Nuvama slashes BSE's target price, citing reduced volumes from NSE changes and SEBI's derivative rules. Explore the ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

Shares of Zee Entertainment rose on Friday after brokerage house Nuvama maintained a 'buy' rating with a target price of Rs ...

In its latest strategy note, Nuvama Institutional Equities said the recent market correction -- worst breadth in the post-Covid era, seem to be India-centric. All this occurred amid low volatility ...